Related Experiment Video

Updated: Jun 21, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media

Masja Straetemans1, Elisabeth A Sanders, Reinier H Veenhoven

  • 1Department of Epidemiology and Biostatistics, University Medical Center Nijmegen, Nijmegen, the Netherlands.

The Pediatric Infectious Disease Journal
|June 12, 2003
PubMed

Insights

Pneumococcal vaccination shows limited effectiveness in preventing acute otitis media (AOM) in young children. Further research is needed for high-risk children, especially with conjugate vaccines.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Antibiotic resistance in acute otitis media (AOM) pathogens necessitates novel prevention strategies.
  • Young children are particularly susceptible to recurrent AOM episodes.

Purpose of the Study:

  • To evaluate the efficacy of pneumococcal vaccination in preventing AOM in children up to 12 years old.

Main Methods:

  • Systematic review of 11 randomized controlled trials involving 46,074 children.
  • Compared pneumococcal vaccination against AOM with control treatments.
  • Calculated vaccine effect using rate ratios (RR) for AOM episodes.

Main Results:

  • Pneumococcal polysaccharide vaccine demonstrated moderate effectiveness in children aged 24 months and older (RR 0.78).
  • Vaccine efficacy was higher in children with a history of prior AOM (RR 0.81) compared to those without (RR 0.92).
  • Pneumococcal conjugate vaccines showed minimal effect in infants and toddlers (RR 0.92).

Conclusions:

  • Large-scale pneumococcal vaccination programs solely for AOM prevention in infancy are not currently recommended.
  • Ongoing trials are crucial to determine the efficacy of conjugate vaccines in high-risk, otitis-prone children over one year of age.
Abstract

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...